Abstract: Provided are novel compounds having a structure of that are useful as emitters in OLEDs.

Abstract: Provided are organic compounds which comprise a pyrrole or imidazole ring which is fused to a 6-membered ring as well as to a further 5- or 6-membered ring, and wherein the pyrrole or imidazole nitrogen is further substituted with a 6-membered ring. Also provided are formulations comprising these organic compounds. Further provided are organic light-emitting devices (OLEDs) and related consumer products that utilize these organic compounds.

Abstract: Tetradentate platinum complexes comprising an imidazole/benzimidazole carbene having a structure of Formula I is disclosed. In Formula I, M is Pd or Pt. These platinum carbenes with the specific substituents disclosed herein are novel and provides phosphorescent emissive compounds that exhibit physical properties that can be tuned, such as sublimation temperature, emission color, and device stability.

Abstract: A compound having the following formula is disclosed. The compound is useful as an emitter in OLED applications.

Abstract: Provided are compounds comprising a plurality of chemical groups, wherein the compound comprises a first ring, wherein the first ring is formed by connecting the plurality of chemical groups one by one with a direct bond to each other in a manner to form one or more closed rings, wherein the first ring is a ring which has a minimum number of a plurality of ring atoms in the one or more closed rings. Also provided are formulations comprising these compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these compounds.

Abstract: A compound of Formula I, is provided. In Formula I, moiety A and moiety B are monocyclic rings or polycyclic ring structures; X1 and X2 are C or N; each RA, RB, RC, RD, RE, RF, and RX is hydrogen or a substituent; at least one of RA, RB, RC, RD, RE, RF, and RX comprises a silyl group; if n=1, then RD is joined with RF to form a ring; if n=0 and m=1, then RD is joined with either RE or RA to form a ring, with the proviso that if RD is joined to RA, then RX is a substituted or unsubstituted aryl or heteroaryl group; and if n=0 and m=0, then the compound has the structure of Formula V, Formulations, OLEDs, and consumer products comprising the compound are also provided.

Abstract: A compound of Formula I wherein at least one of R1 or R2 includes a polycyclic group selected from the group consisting of Formula A, Formula B, and Formula C: wherein X1, X2, X3, and X4 are independently CRA or N; X5, X6, X7, and X8 are independently CRB or N; X9, X10, X11, and X12 are independently CRC or N; X13, X14, X15, and X16 are independently CRD or N; X17, X18, X19, and X20 are independently CRE or N; X21, X22, X23, and X24 are independently CRF or N; X25, X26, X27, and X28 are independently CRG or N; X29, X30, X31, and X32 are independently CRH or N; Y is selected from the group consisting of O, S, NR, and CRR?; the maximum number of N atoms that can connect to each other within each ring is two; with the proviso that R1 does not connect to ring B, and R2 does not connect to ring A, and wherein at least one of RC and RD of Formula A is a direct bond or an organic linker, one of RE and RF of Formula B is a direct bond or an organic linker, or one of RG, RH, and RN of Formula C is a d

Abstract: A compound of Formula I wherein: ring B is a 5-membered heterocyclic ring, or a 6-membered carbocyclic ring; each of X1 and X2 is independently C, CR, or N, with at least one of them being C; each of X3-X11 is independently C, CR, or N, with at least one of them being N, and two adjacent of X3-X7 are carbon-fused to the shown moiety through the linkage indicated by the two squiggly lines; Y is selected from the group consisting of O, S, Se, NR?, CR?R?, and SiR?R?; each of RA and RB independently represents zero, mono, or up to a maximum allowed substitution to its associated ring; each of R, R?, R?, RA, and RB is independently a hydrogen or a substituent selected from the group consisting of —SiR1R2R3 or —GeR1R2R3, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combin

Abstract: Provided are novel organic molecules containing fused indole and benzimidazole moieties, or their boron containing analogs. Also provided are OLEDs and related consumer products that utilize these compounds containing the fused indole and benzimidazole moieties.

Abstract: A compound of Formula I wherein at least one of R1 or R2 includes a polycyclic group selected from the group consisting of Formula A, Formula B, and Formula C: wherein X1, X2, X3, and X4 are independently CRA or N; X5, X6, X7, and X8 are independently CRB or N; X9, X10, X11, and X12 are independently CRC or N; X13, X14, X15, and X16 are independently CRD or N; X17, X18, X19, and X20 are independently CRE or N; X21, X22, X23, and X24 are independently CRF or N; X25, X26, X27, and X28 are independently CRG or N; X29, X30, X31, and X32 are independently CRH or N; Y is selected from the group consisting of O, S, NR, and CRR?; the maximum number of N atoms that can connect to each other within each ring is two; with the proviso that R1 does not connect to ring B, and R2 does not connect to ring A, and wherein at least one of RC and RD of Formula A is a direct bond or an organic linker, one of RE and RF of Formula B is a direct bond or an organic linker, or one of RG, RH, and RN of Formula C is a d

Abstract: A novel compound having a benzimidazole based structure is disclosed that is selected from one of the following structures: The compound is useful in improving photophysical performance of OLEDs.

Abstract: Provided are compounds comprising a first moiety and a second moiety, wherein the first moiety comprises an azabenzene joined to a trivalent nitrogen atom that is part of an at least three-cyclic heteroaromatic ring system. Also provided are formulations comprising these compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these compounds.

Abstract: Provided are macrocyclic compounds comprising at least one eight-membered ring and at least four further 5-membered or 6-membered carbocyclic and heterocyclic rings which may be further substituted. Also provided are formulations comprising these macrocyclic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these macrocyclic compounds.

Abstract: Provided are compounds comprising at least four six-membered rings wherein two atoms of each of these four six-membered rings are connected to form an at least eight membered ring and a further ligand which is connected to the at least eight-membered ring via a linker. Also provided are formulations comprising these compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these compounds.

Abstract: A compound comprising a first ligand LA comprising a structure of Formula I, is provided. In Formula I, moieties A, B, C, and D are each independently a monocyclic ring or a multicyclic fused ring system; each of X1 to X8 is C or N; each independently represents a single bond or a double bond; each of L1, L2, L3, and L4 is independently a direct bond or a linking group; each R, R?, R?, RA, RB, RC, and RD is a hydrogen or a General Substituent; any two adjacent R, R?, R?, RA, RB, RC, and RD may be joined or fused to form a ring; and LA is coordinated to a transition metal M. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: The present invention includes novel compounds containing deuterated or partially deuterated xanthene and thioxanthene structures.

Abstract: Provided are organometallic compounds that include a ligand LA of that are useful as emitters in OLEDs. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound of Formula I: wherein: X1-X8 are each independently C or N, wherein two adjacent X1-X8 are carbon-fused to a structure of Formula II: X9-X12 are each independently C or N; A1, A2, and A3 are each independently selected from the group consisting of O, S, Se, N, NR, CR, CRR?, SiR, SiRR?, GeR, and GeRR?, with at least one of A1 and A2 being N or NR; each occurrence of is independently a single bond or a double bond, wherein one occurrence of is a single bond and one occurrence of is a double bond; each of RA, RB, and RC independently represents zero, mono, or up to a maximum allowed substitution to its associated ring; each of occurrence R, R?, RA, RB, and RC is independently a hydrogen or a substituent selected from the group consisting of Formula III, Formula IV, Formula V, Formula VI, Formula VII, Formula VIII, Formula IX, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, a

Abstract: A compound of Formula I: wherein ring A is a 5-membered or 6-membered aromatic ring; wherein RA, RB, and RC each independently represent mono to the maximum allowable substitution, or no substitution; wherein Y1 is absent or present, and when present is selected from the group consisting of a direct bond, O, S, Se, CRR?, NR, SiRR?, and BR; wherein each X1-X3 is N or CR; wherein at least one of X1-X3 is N; wherein each A1-A5 is independently C or N; wherein the maximum number of N atoms that can connect to each other within each ring is two; wherein each R1, R2, R3, and R4 is independently selected from the group consisting of alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aryl, heteroaryl, and combinations thereof; wherein each R, R?, RA, RB, and RC is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroa